Lodestone’s nanoparticle implant opens the door for a broad spectrum of longitudinal in vivo assays in the tumor microenvironment. Our small-animal system and in vivo assay technology accelerates drug development and increases the success rate of pre-clinical trials.
Company’s Keywords:
<3
<
<